Opaleye Management as of Dec. 31, 2022
Portfolio Holdings for Opaleye Management
Opaleye Management holds 40 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Harrow Health (HROW) | 19.4 | $56M | 3.8M | 14.76 | |
Tela Bio (TELA) | 8.3 | $24M | 2.1M | 11.50 | |
Rhythm Pharmaceuticals (RYTM) | 7.4 | $21M | 735k | 29.12 | |
Ocular Therapeutix (OCUL) | 5.9 | $17M | 6.1M | 2.81 | |
Crinetics Pharmaceuticals In (CRNX) | 4.7 | $13M | 732k | 18.30 | |
Cytokinetics Com New (CYTK) | 4.0 | $12M | 250k | 45.82 | |
Keros Therapeutics (KROS) | 4.0 | $11M | 238k | 48.02 | |
Vaxcyte (PCVX) | 3.0 | $8.5M | 177k | 47.95 | |
Biohaven (BHVN) | 2.6 | $7.5M | 540k | 13.88 | |
4d Molecular Therapeutics In (FDMT) | 2.5 | $7.3M | 330k | 22.21 | |
Protara Therapeutics Com Stk (TARA) | 2.5 | $7.2M | 2.7M | 2.68 | |
Tracon Pharmaceuticals Com New (TCON) | 2.4 | $6.8M | 4.6M | 1.49 | |
Larimar Therapeutics (LRMR) | 2.2 | $6.4M | 1.6M | 4.13 | |
Kalvista Pharmaceuticals (KALV) | 2.2 | $6.2M | 923k | 6.76 | |
Eton Pharmaceuticals (ETON) | 2.1 | $6.1M | 2.2M | 2.82 | |
Edgewise Therapeutics (EWTX) | 1.9 | $5.5M | 611k | 8.94 | |
Proqr Therapeutics Nv Shs Euro (PRQR) | 1.9 | $5.4M | 1.5M | 3.70 | |
Phathom Pharmaceuticals (PHAT) | 1.6 | $4.7M | 418k | 11.22 | |
Xoma Corp Del Com New (XOMA) | 1.6 | $4.5M | 243k | 18.40 | |
Codexis (CDXS) | 1.6 | $4.5M | 958k | 4.66 | |
Urogen Pharma (URGN) | 1.5 | $4.3M | 489k | 8.87 | |
Karyopharm Therapeutics (KPTI) | 1.5 | $4.3M | 1.2M | 3.55 | |
Astria Therapeutics (ATXS) | 1.4 | $3.9M | 262k | 14.89 | |
Liquidia Corporation Com New (LQDA) | 1.2 | $3.6M | 560k | 6.37 | |
Zentalis Pharmaceuticals (ZNTL) | 1.2 | $3.4M | 168k | 20.14 | |
Marinus Pharmaceuticals Com New (MRNS) | 1.1 | $3.3M | 826k | 3.98 | |
Edap Tms S A Sponsored Adr (EDAP) | 1.1 | $3.3M | 307k | 10.66 | |
Aadi Bioscience (AADI) | 1.1 | $3.2M | 252k | 12.83 | |
Morphosys Sponsored Ads (MOR) | 1.1 | $3.2M | 897k | 3.58 | |
Mersana Therapeutics (MRSN) | 0.9 | $2.7M | 460k | 5.86 | |
Theseus Pharmaceuticals | 0.9 | $2.7M | 535k | 4.98 | |
Fennec Pharmaceuticals (FENC) | 0.9 | $2.6M | 272k | 9.60 | |
Ideaya Biosciences (IDYA) | 0.9 | $2.5M | 139k | 18.17 | |
Stereotaxis Com New (STXS) | 0.9 | $2.5M | 1.2M | 2.07 | |
Bioatla (BCAB) | 0.8 | $2.2M | 262k | 8.25 | |
Fortress Biotech | 0.5 | $1.3M | 2.1M | 0.66 | |
Allakos (ALLK) | 0.4 | $1.3M | 154k | 8.42 | |
Theravance Biopharma (TBPH) | 0.3 | $983k | 88k | 11.22 | |
Trevi Therapeutics (TRVI) | 0.3 | $936k | 485k | 1.93 | |
Modular Medical Com New (MODD) | 0.2 | $490k | 245k | 2.00 |